Search Results 71-80 of 18588 for ibs
Eluxadoline has been approved by the FDA for people with IBS-D but it is not known whether it will work the same way in people with IBS-D who also have BAM.
Show more areas of focus for Irina Todorov, M.D.. Research. Mayo Clinic doctors are conducting clinical trials of new therapies for IBS -related constipation ...
Stool studies. A stool sample may be used to test for blood or organisms, such as infection-causing bacteria or, rarely, parasites, in the stool. These can be ...
difficile disease (rCDI) and using a combination of clinical and laboratory markers to determine disease versus post infectious irritable bowel syndrome (IBS) ...
Genetics of IBS and functional diarrhea. Evaluation of clinical tests and treatment interventions of functional gastrointestinal disorders. Patient education, ...
About this study. The purpose of this study is to determine if people with diarrhea predominant IBS (IBS-D) from the community are interested in making ...
... IBS, and to determine differences in peripheral metabolites, proteins and lipids in volunteers with and without Rome IV defined Campylobacter jejuni PI-IBS.
About this study. The purpose of this study is to measure 48 hour fecal bile acids in IBS-D adolescents and compare it to HC; measure serum C4 and FGF-19 in ...
About this study. The primary objectives of this study are to explore the therapeutic effect of eluxadoline in treating IBS-D in pediatric patients 12-17 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.